Part 11 Comment Period Extension Possible – FDA Safety Officer
This article was originally published in The Tan Sheet
Executive Summary
FDA is considering reopening the comment period on the electronic records and signatures rule and may reschedule a public meeting to discuss changes, according to Consumer Safety Officer George Smith
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning